T. Burke

发表

Biologic course of cervical human papillomavirus infection

W. Hoskins, J. Nash, T. Burke, 1987, Obstetrics and gynecology.

The effect of prolonged cisplatin‐based chemotherapy on progression‐free survival in patients with optimal epithelial ovarian cancer: ‘Maintenance’ therapy reconsidered

J. Wharton, N. Atkinson, M. Mitchell, 1993, Gynecologic oncology.

Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva

C. Stringer, J. Wharton, D. Gershenson, 1990, Gynecologic oncology.

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

J. Wharton, D. Gershenson, T. Burke, 1991, Gynecologic oncology.

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide

M. Morris, D. Gershenson, J. Kavanagh, 1992, Gynecologic oncology.

Widespread lymph node metastases in a patient with microinvasive cervical carcinoma

Jeffrey. Woodward, T. Burke, P. Heller, 1990, Gynecologic oncology.

Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early‐stage high‐risk endometrial cancer: A preliminary analysis

J. Wharton, D. Gershenson, A. Gordon, 1991, Gynecologic Oncology.

Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence

J. Wharton, M. Morris, D. Gershenson, 1991, Obstetrics and gynecology.